Corcept Therapeutics Inc. (CORT)

17.37
0.22 1.30
NASDAQ : Health Technology
Prev Close 17.59
Open 17.57
Day Low/High 17.57 / 17.78
52 Wk Low/High 8.90 / 25.96
Volume 50.80K
Avg Volume 1.84M
Exchange NASDAQ
Shares Outstanding 114.83M
Market Cap 2.09B
EPS 1.10
P/E Ratio 17.47
Div & Yield N.A. (N.A)

Latest News

Target, Triton, Covanta: 'Mad Money' Lightning Round

Target, Triton, Covanta: 'Mad Money' Lightning Round

Jim Cramer highlights Target, Triton, Covanta, and Corcept Therapeutics.

This Is the New, New Normal: Cramer's 'Mad Money' Recap (Wednesday 2/7/18)

This Is the New, New Normal: Cramer's 'Mad Money' Recap (Wednesday 2/7/18)

Jim Cramer says fundamentals of a stock matter less than the mechanics of how this market works. Investors need to be able to handle this kind of volatility.

First Week of CORT August 2018 Options Trading

First Week of CORT August 2018 Options Trading

Investors in Corcept Therapeutics Inc saw new options begin trading this week, for the August 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Corcept, Pure Storage, Nutanix, VMWare: 'Mad Money' Lightning Round

Corcept, Pure Storage, Nutanix, VMWare: 'Mad Money' Lightning Round

Jim Cramer is bullish on Corcept Therapeutics, Pure Storage, Nutanix, VMWare, Tellurian, Switch.

A New and Different Kind of Market: Cramer's 'Mad Money' Recap (Thursday 12/21)

A New and Different Kind of Market: Cramer's 'Mad Money' Recap (Thursday 12/21)

Jim Cramer says there's just not enough stock to meet the demand of the buyers who have had to radically switch their orientation -- thanks to the hot economy and the tax bill.

First Week of December 15th Options Trading For Corcept Therapeutics (CORT)

First Week of December 15th Options Trading For Corcept Therapeutics (CORT)

Investors in Corcept Therapeutics Inc saw new options begin trading this week, for the December 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CORT options chain for the new December 15th contracts and identified one put and one call contract of particular interest.

Alaska Air, Corcept Therapeutics, First Solar: 'Mad Money' Lightning Round

Alaska Air, Corcept Therapeutics, First Solar: 'Mad Money' Lightning Round

Jim Cramer is bullish on Alaska Air Group, Corcept Therapeutics, First Solar and more.

Markets Focus on Business: Cramer's 'Mad Money' Recap (Monday 8/28/17 )

Markets Focus on Business: Cramer's 'Mad Money' Recap (Monday 8/28/17 )

Jim Cramer says people care about natural disasters, but the markets are moved by data points, such as Apple's iPhone news.

Corcept Therapeutics Stock Sees Short Interest Decline 11.2%

Corcept Therapeutics Stock Sees Short Interest Decline 11.2%

The most recent short interest data has been released for the 07/31/2017 settlement date, which shows a 910,088 share decrease in total short interest for Corcept Therapeutics Inc , to 7,204,716, a decrease of 11.22% since 07/14/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

CORT September 15th Options Begin Trading

CORT September 15th Options Begin Trading

Investors in Corcept Therapeutics Inc saw new options become available today, for the September 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CORT options chain for the new September 15th contracts and identified one put and one call contract of particular interest.

CORT Crosses Above Average Analyst Target

In recent trading, shares of Corcept Therapeutics Inc have crossed above the average analyst 12-month target price of $11.00, changing hands for $11.23/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Interesting CORT Put And Call Options For February 2018

Investors in Corcept Therapeutics Inc saw new options begin trading this week, for the February 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHUY, CMCM, CORT, ETSY, EVH, GLPI, HIIQ, PPG, RSPP, SBR, SKYW Downgrades: ALSK, COMM, FOX, MATX, STFC, WINS Initiations: AKTS, QHC, SCWX Read on to get TheStreet Quant Ratings' detailed report:

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARE, FNFV, GLBZ, SLM, UFPT, YY Downgrades: AFSI, CORT, CUTR, SID, SYF, TIS Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

First Week of June 16th Options Trading For Corcept Therapeutics (CORT)

Investors in Corcept Therapeutics Inc saw new options become available this week, for the June 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CORT options chain for the new June 16th contracts and identified one put and one call contract of particular interest.

Corcept Therapeutics Reaches Analyst Target Price

In recent trading, shares of Corcept Therapeutics Inc have crossed above the average analyst 12-month target price of $10.75, changing hands for $11.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

First Week of November 17th Options Trading For Corcept Therapeutics (CORT)

Investors in Corcept Therapeutics Inc saw new options begin trading this week, for the November 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Corcept Therapeutices Eyes Another Double

Corcept Therapeutices Eyes Another Double

Biotech has a base pattern than can support a lot more upside..

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CORT, GCAP, VC Downgrades: AXU, FNHC, KBR, MOV, SUI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

CORT Crosses Above Average Analyst Target

In recent trading, shares of Corcept Therapeutics Inc have crossed above the average analyst 12-month target price of $8.75, changing hands for $8.85/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Corcept Therapeutics is Now Oversold (CORT)

Corcept Therapeutics is Now Oversold (CORT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TheStreet Quant Rating: B (Buy)